ArticleAnnals of translational medicine2022

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001).

Xiaobin Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.